Donaldson Narrows FY Outlook Upward, Beats Q3 Profit & Revenue Estimates
DCI sits 22% above its 52-week low of $67.705 on elevated volume (2.6× avg).
Summary
Donaldson reported strong third-quarter results, with adjusted earnings of $1.06 per share and sales of $995.1 million, both exceeding analyst estimates. Following this performance, the company narrowed its full-year organic sales growth outlook to 3%-5% (from 1%-5%) and raised the low end of its adjusted EPS guidance to $3.94-$4.01 (from $3.93-$4.01). This upward revision to the full-year outlook, driven by strong Mobile and Life Sciences segments, provides a more positive and certain financial trajectory for the company.
At the time of this announcement, DCI was trading at $82.29 on NYSE in the Manufacturing sector, with a market capitalization of approximately $9.5B. The 52-week trading range was $67.71 to $112.84. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.